{
    "clinical_study": {
        "@rank": "121004", 
        "arm_group": [
            {
                "arm_group_label": "Lung volume recruitment", 
                "arm_group_type": "Experimental", 
                "description": "Lung volume recruitment twice daily for 9 months"
            }, 
            {
                "arm_group_label": "Standard care", 
                "arm_group_type": "No Intervention", 
                "description": "Standard care"
            }
        ], 
        "brief_summary": {
            "textblock": "Multiple sclerosis is a neurological disease that can affect lung function and cough\n      efficacy. This pilot study will examine whether the lung volume recruitment technique can\n      slow down the decline in lung function and cough."
        }, 
        "brief_title": "Lung Volume Recruitment for Lung Function and Cough Impairment in Multiple Sclerosis", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Multiple Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Multiple Sclerosis", 
                "Sclerosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  History of multiple sclerosis, diagnosed by a neurologist in accordance with the 2010\n             McDonald criteria\n\n        Exclusion Criteria:\n\n          -  Concomitant parenchymal pulmonary disease or pleural disease\n\n          -  Symptomatic cardiomyopathy\n\n          -  Unable to perform pulmonary function testing or lung volume recruitment, due to\n             comprehension or cooperation issues, physical inability such as bulbar or cerebellar\n             dysfunction\n\n          -  Contra-indication to pulmonary function testing or lung volume recruitment such as\n             myocardial infarction, bleeding aortic aneurysm, intracranial hemorrhage within the\n             previous month\n\n          -  Known susceptibility to pneumothorax or pneumomediastinum\n\n          -  Not competent to provide informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "35", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01891071", 
            "org_study_id": "MS-LVR-01", 
            "secondary_id": "20120570-01H"
        }, 
        "intervention": {
            "arm_group_label": "Lung volume recruitment", 
            "description": "Inflation of the lungs to their maximal insufflation capacity by the consecutive delivery, by a manual resuscitator in this study, of volumes of air that are held with a closed glottis", 
            "intervention_name": "Lung volume recruitment", 
            "intervention_type": "Procedure", 
            "other_name": [
                "Air stacking", 
                "Glossophayngeal breathing"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Multiple sclerosis", 
            "Lung volume recruitment", 
            "Pulmonary function impairment", 
            "Cough impairment"
        ], 
        "lastchanged_date": "July 30, 2013", 
        "location": {
            "contact": {
                "email": "dmckim@ottawahospital.on.ca", 
                "last_name": "Doug A. McKim, MD", 
                "phone": "613-737-8899", 
                "phone_ext": "16448"
            }, 
            "facility": {
                "address": {
                    "city": "Ottawa", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "K1H 8L6"
                }, 
                "name": "The Ottawa Hospital"
            }, 
            "investigator": {
                "last_name": "Doug A McKim, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Lung Volume Recruitment for Lung Function and Cough Impairment in Multiple Sclerosis", 
        "overall_official": [
            {
                "affiliation": "Universit\u00e9 de Sherbrooke", 
                "last_name": "Nadim Srour, MD, MSc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "The Ottawa Hospital", 
                "last_name": "Douglas A McKim, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Rate of decline of FVC (forced vital capacity)", 
            "safety_issue": "No", 
            "time_frame": "up to 9 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01891071"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Rate of decline of peak cough flow", 
                "safety_issue": "No", 
                "time_frame": "baseline, 2, 4, 6 and 9 months"
            }, 
            {
                "measure": "Change from baseline in FVC at 2, 4, 6 and 9 months", 
                "safety_issue": "No", 
                "time_frame": "baseline vs 2, 4, 6 and 9 months"
            }, 
            {
                "measure": "Change from baseline in peak cough flow at 2, 4, 6 and 9 months", 
                "safety_issue": "No", 
                "time_frame": "baseline vs 2, 4, 6 and 9 months"
            }
        ], 
        "source": "Ottawa Hospital Research Institute", 
        "sponsors": {
            "collaborator": {
                "agency": "The Ottawa Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Ottawa Hospital Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}